Blog sidebar

The incisional pain model now available in mice

Preclinical investigations in postoperative pain: where are we now at ANS Biotech? From theory…. Postoperative pain (POP) is defined as a transient but extremely strong activation of the nociceptive network. Mechanical hyperalgesia is observed by applying force directly on the wounds of patients after various surgical procedures such as inguinal herniorrhaphy, open cholecystectomy and abdominal [...]

Upcoming ALGOGram™ Fall SESSION

The registration for the upcoming ALGOGram™ session is now open! A decision-making guide to accelerate your Pain programs.

ALGOGram™ back to school SESSION: Last call

Last call for the upcoming ALGOGram Back to school session. Don’t miss it! √ A decision-making guide in developing the all-important product profile for your test compounds.

A new readout to meet your needs

The most appropriate test for translational research Von Frey hairs, initially designed by the German physiologist Max von Frey (1852–1932), are today considered as a standard for assessing tactile nociception both at clinical and preclinical levels. Nowadays, the set is made up of twenty nylon monofilaments of various diameters that can induce a force ranging [...]

OSTEOARTHRITIS PAIN: MECHANISMS AND PHARMACOLOGY – 24JUNE2021

Osteoarthritis (OA) of the knee is a complex peripheral joint disorder. This degenerative disease involving several joint tissues is characterized by damages to the articular cartilage. Pain is the primary symptom of OA and is the driving factor for patients to seek medical help. OA-associated pain is described as dull, aching pain that persists over time, but short episodes of more intense pain, known as flares, are also experience by many individuals.

ALGOGram™: highlights from the first half year 2021

ALGOGram™, more and more popular! Key numbers Since the beginning of the year, the two ALGOGram™ sessions have encountered a great success. Through the Spring and Summer sessions: 31 slots have been booked 10 studies have been performed 6 new clients have experienced our unique in vivo screening tool All the ANS Biotech team thanks [...]

REGISTER NOW FOR ANS BIOTECH NEXT WEBINAR, JUNE 24TH

Osteoarthritis (OA) of the knee is a complex peripheral joint disorder. This degenerative disease involving several joint tissues is characterized by damages to the articular cartilage. Pain is the primary symptom of OA and is the driving factor for patients to seek medical help. OA-associated pain is described as dull, aching pain that persists over time, but short episodes of more intense pain, known as flares, are also experience by many individuals.

OSTEOARTHRITIS: CURRENT SITUATION

Musculoskeletal disorders represent the fourth cause of disability following neuropsychiatric disorders, cancers and cardiovascular diseases in both developed and developing countries. These injuries include a variety of disorders that cause pain in bones, joints, muscles, and surrounding structures. Osteoarthritis (OA) is considered as the most common of the articular disorders and is frequently cited as [...]

BIO US 2021

One month remaining before digital BIO US 2021! On June 14-18, Yassine will attend BIO International Convention Digital 2021. He will be pleased to evaluate whether the in vivo services offered by ANS Biotech can be helpful for your research projects. Without further delay, join him to the event!

FOCUS ON OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY: MECHANISMS AND PHARMACOLOGY

For this first blog, Laurent DIOP, Chief Scientific Officer at ANS Biotech, would like to focus on Neuropathic Pain and more specifically on Chemotherapy-induced peripheral neuropathy (CIPN). Since its creation in 2006, ANS Biotech is fully involved in this thematic and daily serves its Clients, all around the world, using relevant in vivo models for [...]
X